(Q53549540)
Statements
Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALS. (English)
1 reference
S J Ackerman
1 reference
E M Sullivan
1 reference
K M Beusterien
1 reference
H M Natter
1 reference
D F Gelinas
1 reference
D L Patrick
1 reference
1 February 1999
1 reference
15
1 reference
2
1 reference
179-195
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference